See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NYSE:ATNM

Actinium Pharmaceuticals Stock News

etoro logo Buy ATNM
*Your capital is at risk
$0.84
-0.0001 (-0.0119%)
At Close: Jul 31, 2026
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile

Actinium Pharma Highlights Presenation Of 2 Oral, 4 Poster Presentations For AWE At Targeted-Alpha-Therapy International Symposium

 12:00am, Monday, 08'th Apr 2019

The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial

 12:00am, Tuesday, 02'nd Apr 2019

What Makes Actinium (ATNM) a New Buy Stock

 12:00am, Monday, 01'st Apr 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

 12:00am, Saturday, 30'th Mar 2019

Actinium Reports Novel Combo Of Actimab-A, Venetoclax Accepted For Poster Presentation At AACR Meeting

 12:00am, Wednesday, 20'th Mar 2019

Actinium Pharmaceuticals misses by $0.03

 12:00am, Tuesday, 19'th Mar 2019

Actinium's Iomab-B shows positive action in late-stage study

 12:00am, Monday, 25'th Feb 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs

 12:00am, Friday, 22'nd Feb 2019

Centers For Medicaid, Medicare Has Proposed Coverage With Evidence Development For CAR-T Therapy, Decision Would Provide Nationwide Consistency In CMS Coverage

 12:00am, Friday, 15'th Feb 2019

Actinium Offers Update On Patent Portfolio For its Iomab-ACT Next-Generation CAR-T Lymphodepletion Program

 12:00am, Wednesday, 06'th Feb 2019

Actinium Initiates Second Dosing Cohort of Novel Combination Trial with Actimab-A and CLAG-M Salvage Regimen at Medical College of Wisconsin

 12:00am, Monday, 04'th Feb 2019

Actinium Completes First Module of Collaborative Research Program with Astellas, Second Module Initiated

 12:00am, Thursday, 17'th Jan 2019

Oppenheimer sees 1H19 risk for smid-cap biotech

 12:00am, Thursday, 27'th Dec 2018

Actinium Highlights Post Presentation Of Actimab-A Phase 2 Trial In Older Patients With Unfit AML At ASH, Showed 'Single Agent Activity of the CD33 Antibody Radiation Conjugate'

 12:00am, Monday, 03'rd Dec 2018

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

 12:00am, Sunday, 02'nd Dec 2018
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE